Efficient large scale preparation of neutral endopeptidase/ angiotensin-converting enzyme dual inhibitor CGS30440

Organic Process Research and Development

Volumn 2, Issue 4, 1998, Pages 238-244

  Johnson, Erik P ^a   Cantrell Jr , William R ^a   Jenson, Todd M ^a   Miller, Scott A ^a   Parker, David J ^a   Reel, Noela M ^a   Sylvester, Leo G ^a   Szendroi, Robert J ^a   Vargas, Kevin J ^a   Xu, Jean ^a   Carlson, John A ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032350901     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op970242s     Document Type: Article

References (5)

1. Fink, C. A.; Carlson, J. E.; McTaggart, P. A.; Qiao, Y.; Webb, R.; Chatelain, R.; Jeng, A. Y.; Trapani, A. J. J. Med. Chem. 1996, 39, 3158-3168 and refs 1-17 contained therein.
2. Chatterjee, K. Heart Dis. Stroke 1992, 1, 128.
3. (a) Winquist, R. J.; Hintze, T. H. Pharmacol. Ther. 1990, 48, 417-426.
4. (b) Johnson, C. I.; Hodsman P. G.; Kohzuki, M.; Casley, D. J.; Fabris, B.; Phillips, P. A. Am. J. Med. 1989, 87, 24S-28S.
5. (a) Trippodo, N. C.; Robl, J. A.; Asaad, M. M.; Bird, J. E.; Panchal, B. C.; Schaeffer, T. R.; Fox, M.; Giancarli, M. R.; Cheung, H. S. J. Pharmacol. Exp. Ther. 1995, 275, 745-752.